| Title: |
Indications and contraindications to platelet‐rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections) |
| Authors: |
Eymard, Florent; Louati, Karine; Noel, Éric; Abouqal, Redouane; Adam, Philippe; Allali, Fadoua; Antherieu, Gabriel; Caers, Jo; Cognasse, Fabrice; Collado, Hervé; Darrieutort-Laffite, Christelle; Frère, Corinne; Frey, Alain; Gavillet, Mathilde; Gremeaux, Vincent; Heiblig, Mael; Jerusalem, Guy; Joly, Charlotte; Kaux, Jean‐françois; Lamontagne, Martin; Leclerc, Mathieu; Léonard, Philippe; Lepeule, Raphaël; Lopez-Trabada-Ataz, Daniel; Magalon, Jérémy; Michel, Fabrice; Ornetti, Paul; Oury, Cécile; Pons-Tostivint, Elvire; Real, Fernando; Robert, Ghislaine; Sanchez, Mikel; Silvestre, Alain; Bard, Hervé |
| Contributors: |
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Hôpital privé Jean Mermoz Lyon; Université Mohammed V de Rabat Agdal (UM5); Clinique Médipôle Garonne; El Ayachi Hospital; Hospices Civils de Lyon (HCL); Centre Hospitalier Universitaire de Liège (CHU-Liège); Santé Ingénierie Biologie Saint-Etienne (SAINBIOSE); Centre Ingénierie et Santé (CIS-ENSMSE); École des Mines de Saint-Étienne (Mines Saint-Étienne MSE); Institut Mines-Télécom Paris (IMT)-Institut Mines-Télécom Paris (IMT)-École des Mines de Saint-Étienne (Mines Saint-Étienne MSE); Institut Mines-Télécom Paris (IMT)-Institut Mines-Télécom Paris (IMT)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM); Établissement Français du Sang Auvergne-Loire Saint-Etienne (EFS Auvergne-Loire - Saint-Étienne); Établissement Français du Sang La Plaine Saint-Denis (EFS); Établissement Français du Sang Auvergne-Rhône-Alpes Lyon (EFS Auvergne-Rhône-Alpes - Lyon); Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP); Université Jean Monnet - Saint-Étienne (UJM); Assistance Publique - Hôpitaux de Marseille (APHM); Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes); CHI Poissy - Saint-Germain-en-Laye; Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital Lausanne (CHUV); Immuno-Biologie des Lymphomes CIRI (CIRI-LIB); Centre International de Recherche en Infectiologie (CIRI); École normale supérieure de Lyon (ENS de Lyon); Université de Lyon-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL); Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon); Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS); Service d’Hématologie Centre Hospitalier Lyon Sud - HCL; Centre Hospitalier Lyon Sud CHU - HCL (CHLS); Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL); CHU Sainte Justine Montréal; Hôpital Jean Minjoz Besançon; Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon); GIGA Institute Université de Liège (GIGA Liège ); Université de Liège = University of Liège = Universiteit van Luik = Universität Lüttich (ULiège); Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL); Institut Pasteur de Lille; Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS); Medical Office, Redmond, Washington, USA.; Vithas Vitoria Hospital, Arthroscopic Surgery Unit, Vitoria, Spain.; Clinique du sport de Bordeaux-Mérignac; Medical Office Vaudoyer, Paris |
| Source: |
ISSN: 0942-2056. |
| Publisher Information: |
CCSD; Springer Verlag |
| Publication Year: |
2025 |
| Collection: |
Université Jean Monnet – Saint-Etienne: HAL |
| Subject Terms: |
PRP; contraindications; formal consensus; musculoskeletal diseases; recommendations; [SDV]Life Sciences [q-bio] |
| Description: |
International audience ; Purpose Platelet‐rich plasma (PRP) could be a vector for certain diseases, and its composition may vary by pathologic condition. The main comorbidities that could affect PRP composition are infectious, oncologic and haematologic. In addition to potential alteration of clinical response, these pathologies could have a significant impact on the local tolerance of PRP as well as a risk of disease dissemination to the injection site. To date, there are few specific recommendations related to these comorbidities to guide clinicians. Therefore, the International Research Group on Platelet Injections (GRIIP) supported a consensus project to develop these recommendations. Methods Following the ‘recommendations by formal consensus’ methodology, a steering committee performed a literature review and drafted an initial set of recommendations. They were evaluated by an international rating group (15 specialists in musculoskeletal [MSK] diseases, five haematologists, four oncologists, three infectiologists and four scientists specialising in platelet physiology). From this rating, the first set of recommendations was discussed in a plenary meeting and then modified by the steering committee. Finally, four overarching principles and 23 recommendations were re‐evaluated by the rating group. Recommendations were classified as appropriate or not, with strong or relative agreement, or uncertain. Results From the 23 recommendations, 10 concerned infectious diseases (viral and bacterial infections; dialysis; immunosuppressive drugs; dental care…), five oncologic diseases (local tumour; cured, active or in remission cancer…) and eight haematologic diseases (cytopenia; cured, active or stabilised cured hemopathy; monoclonal gammopathy…). All were considered appropriate by the experts (median = 9; range = 8–9), with strong or relative agreement. Due to the paucity of literature data, the recommendations are mainly based on expert opinion (Grade D). Conclusion This consensus project provides four overarching ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/40260684; PUBMED: 40260684 |
| DOI: |
10.1002/ksa.12682 |
| Availability: |
https://hal.science/hal-05336422; https://hal.science/hal-05336422v1/document; https://hal.science/hal-05336422v1/file/Knee%20surg%20%20sports%20traumatol%20%20arthrosc%20-%202025%20-%20Eymard%20-%20Indications%20and%20contraindications%20to%20platelet%E2%80%90rich%20plasma.pdf; https://doi.org/10.1002/ksa.12682 |
| Rights: |
https://creativecommons.org/licenses/by-nc/4.0/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.472DF572 |
| Database: |
BASE |